**Operational Metadata**
- **Documented notebook path:** `docs/notebooks/03_EDA_subset_documentation.md`
- **Five-track role:** Subset integrity and structure validation track (Track 3 of 5)
- **Status:** Completed
- **Purpose:** Document integrity checks, alignment decisions, imbalance assessment, and global structure exploration for the Vitamin D transcriptomic subset.
- **Main inputs:** Candidate signature metadata, expression matrix exports, and supporting cell/compound/gene metadata tables.
- **Main outputs / artifacts:** Cleaned aligned expression-complete subset (258 signatures), QC/imbalance diagnostics, and PCA-centered global structure interpretation artifacts.

# EDA 03 — Vitamin D Transcriptomic Subset (LINCS L1000): Integrity Checks + Global Structure

## Purpose

This notebook validates and characterizes the **curated Vitamin D transcriptomic subset** used throughout the project.  
The focus here is not “deep biology” yet, but **dataset integrity + global structure**:

1. Verify that all exported tables are consistent and usable (sanity checks).
2. Confirm that the expression matrix behaves as expected for Level 5 moderated *z*-scores.
3. Quantify representation across **compounds** and **cell lines** (imbalance matters).
4. Explore global similarity among signatures via **PCA** and summarize variance structure.
5. Export a clean, aligned dataset for downstream analyses (models + hypothesis-driven biology).

---

## Dataset Definition (what this notebook assumes)

This notebook operates on a subset restricted to:

- **Compounds (7):** calcitriol, calcipotriol, paricalcitol, maxacalcitol, ercalcitriol, tacalcitol, seocalcitol  
- **Cell lines (5):** PC3, MCF7, A549, U2OS, HA1E  
- **Perturbation time:** 24 hours  
- **Expression layer:** LINCS Level 5 (moderated z-scores)

---

## Working Hypothesis (starting point)

Even within a “same pathway” perturbation family (Vitamin D analogs), **cellular context will explain more of the global transcriptional structure than compound identity**.

Concretely, we expect:
- Signatures to show **stronger grouping by cell line** than by analog in low-dimensional embeddings (PCA/UMAP).
- Compounds to look **partially overlapping** globally (shared Vitamin D program), with differences emerging more clearly **within** a cell line and/or across dose ranges.
- Quality and strength metrics (e.g., signal intensity proxies) to vary by cell line, influencing separability.

This hypothesis informs the next steps: stratified analyses by cell line, dose-aware contrasts, and models that include cell identity as a primary driver.

---

## Data Loading and Sanity Checks

We load:
- `sig_meta` (signature-level metadata)
- `exp_df` (gene expression matrix: genes × signatures)
- supporting metadata tables (cells, compounds, genes)

### Key sanity check results

- **Cell metadata**
  - Minor missing annotation(s) only (e.g., growth pattern).
  - No duplicates → usable as-is.

- **Compound metadata**
  - Some annotation columns may be entirely missing (e.g., aliases).
  - Core identifiers are complete → keep, ignore empty columns if not needed.

- **Gene metadata**
  - Small fraction of genes missing external identifiers (e.g., Ensembl).
  - No duplicates → acceptable for transcriptomics workflows.

- **Signature metadata**
  - Complete and duplicate-free → ideal.

- **Expression matrix consistency issue**
  - The exported expression matrix contains a subset of signatures with **all values missing (all-NaN columns)**.
  - Outcome: **signature metadata exists for more signatures than the expression matrix actually contains with signal**.

### Decision taken (critical cleaning step)

To prevent silent downstream errors (misalignment, biased summaries, broken models):

1. **Remove empty signatures** (all-NaN columns) from the expression matrix.
2. **Filter and re-align `sig_meta`** to keep only signatures that truly exist in the cleaned expression matrix.
3. Keep other metadata tables unchanged (they remain valid reference maps).

**Result:** a final set of **258 expression-complete manuscript signatures** with expression data, consistently aligned with metadata-level candidates and downstream cleaned exports.

---

## Candidate Metadata Signature Coverage and Imbalance (Compound + Cell Line)

Before expression completeness cleanup, the metadata-level candidate set contains **422 signatures**. The counts below describe that candidate metadata set and are distinct from the final **258 expression-complete manuscript signatures** used for downstream analyses.

### By compound (candidate metadata signatures; n)
- **calcitriol:** 115  
- **maxacalcitol:** 60  
- **ercalcitriol:** 57  
- **tacalcitol:** 57  
- **seocalcitol:** 57  
- **paricalcitol:** 45  
- **calcipotriol:** 31  

**Interpretation**
- The dataset is **compound-imbalanced**, dominated by calcitriol.
- Any compound-level conclusion should either:
  - use stratified comparisons, or
  - apply weighting / resampling strategies, or
  - report uncertainty driven by unequal sample sizes.

### By cell line (candidate metadata signatures; n)
- **MCF7:** 116  
- **A549:** 104  
- **HA1E:** 92  
- **PC3:** 89  
- **U2OS:** 21  

**Interpretation**
- U2OS is **strongly underrepresented**, which can reduce power and inflate variance in that subgroup.
- This reinforces the need for **cell-aware** analyses (the hypothesis already expects cell line to dominate structure).

---

## Global Distribution of Expression Values (Level 5 z-scores)

We inspect the global distribution across all genes and signatures to confirm:
- values are centered near zero,
- the range is plausible for moderated z-scores,
- extreme values exist but do not indicate systematic corruption.

### Outcome
- Expression values are **tightly centered around 0**.
- Most values fall within an expected range, with a small tail of extremes typical in high-dimensional perturbational expression data.
- No evidence of systematic drift or scaling artifacts.

---

## Validation of Perturbation Time and Dose

Even if the subset was pre-filtered, this notebook verifies **metadata consistency**:

- **Perturbation time:** confirm all signatures are 24h (no leakage).
- **Dose:** quantify dose ranges and variability across compounds.

### Outcome
- 24h exposure is consistent across the cleaned set.
- Dose spans multiple orders of magnitude (e.g., ~0.01 µM to 10 µM).
- Dose heterogeneity is a plausible driver of within-compound variability and should be handled explicitly later.

---

## PCA — Global Similarity Structure

We run PCA on the cleaned expression matrix to:
- visualize global clustering tendencies,
- detect outliers,
- test whether **cell line separation** emerges more strongly than compound separation (hypothesis check).

### Key result (PCA1/PCA2)
- PC1 explains **~13.6%**
- PC2 explains **~5.4%**

### Interpretation
- **No strong global separation by compound** in the first two PCs, consistent with a shared Vitamin D response program.
- **Clearer structure by cell line** than by compound indicates that cellular context contributes more to global variance than analog identity in low-dimensional space.
- The modest variance captured by each PC is expected in transcriptomic data, where signal is distributed across many axes.

---

## Scree Plot + Variance Thresholds (how many PCs matter?)

We quantify how many PCs are needed to capture common variance thresholds:

- **~27 PCs → 50% variance**
- **~62 PCs → 70% variance**
- **~91 PCs → 80% variance**
- **~138 PCs → 90% variance**
- **~177 PCs → 95% variance**

### Interpretation
- This is a classic high-dimensional regime: **no single dominant axis**.
- For downstream work, the first ~50–100 PCs are a reasonable compromise for:
  - association tests (e.g., ANOVA across metadata),
  - batch/structure diagnostics,
  - building compact representations for models.
- Biology-focused contrasts (dose-response, compound ranking within cell line, pathway analysis) should be done as targeted analyses rather than “just PCA”.

---

## Outputs (for reproducibility)

We export cleaned, aligned artifacts:

- **Expression matrix (`exp_clean`) → Parquet**
  - preserves gene index efficiently
  - faster I/O for downstream notebooks and modeling

- **Signature metadata (`sig_meta_clean`) → CSV**
  - `sig_id` remains the primary key
  - keeps metadata portable and easy to inspect

These exported files are treated as the **single source of truth** for the remainder of the project.

---
